PubMed · 11499490
Solid-phase analysis method for (S)-[18F]fluorocarazolol and its metabolites.
Abstract
(S)-[18F]Fluorocarazolol is a radiopharmaceutical developed to quantitatively assess beta-adrenergic receptors in vivo via positron emission tomography imaging. Since radioactive metabolites of (S)-[18F]fluorocarazolol rapidly appear in the plasma, methods for conveniently and reliably evaluating plasma for (S)-[18F]fluorocarazolol content are required. Here we present methods and validation of an approach using commercial extraction cartridges that is faster and more convenient than an approach using internal-surface reverse-phase chromatography but yields comparable results.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
R F Muzic, B Landmeier, Z Zhang, L Zheng, M S Berridge. 2001-08-15. Solid-phase analysis method for (S)-[18F]fluorocarazolol and its metabolites.. https://doi.org/10.1016/s0378-4347(01)00233-x
Cite the original work for its findings. Save a collection to share your selection of sources.